SCHEMBL6000571

SCHEMBL6000571

O=C(O)C1CCN(Cc2nc(-c3ccc(NCCc4ccc(C5CCCCC5)cc4)cc3)cs2)CC1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
S1PR1 P21453 5/20 0.42
S1PR4 O95977 3/20 0.42
S1PR5 Q9H228 3/20 0.42
S1PR3 Q99500 2/20 0.42
MEN1 O00255 2/20 0.39
NPC1 O15118 2/20 0.39
RAB9A P51151 2/20 0.39
KMT2A Q03164 2/20 0.39
GPBAR1 Q8TDU6 1/20 0.39
POLB P06746 1/20 0.39
MRE11 P49959 1/20 0.38
MAPK1 P28482 1/20 0.38
CTSL P07711 2/20 0.38
CTSB P07858 2/20 0.38
CTSS P25774 2/20 0.38
NAMPT P43490 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
TRPA1 O75762 1/20 0.36
SPHK2 Q9NRA0 1/20 0.36
SPHK1 Q9NYA1 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5999100 0.91 S1PR1 (0.44) S1PR1S1PR4S1PR5S1PR3MEN1
SCHEMBL6000650 0.90 MAPK1 (0.40) S1PR1S1PR4S1PR5S1PR3MEN1
SCHEMBL6000920 0.85 MEN1 (0.39) MEN1NPC1RAB9AKMT2APOLB
SCHEMBL6001096 0.83 CTSL (0.39) S1PR1S1PR4S1PR5S1PR3MEN1
SCHEMBL6001067 0.83 RAB9A (0.42) S1PR1MEN1NPC1RAB9AKMT2A
SCHEMBL6000564 0.82 S1PR1 (0.42) S1PR1S1PR4S1PR5S1PR3MRE11
SCHEMBL6000064 0.81 NPC1 (0.41) MEN1NPC1RAB9AKMT2APOLB
SCHEMBL5999229 0.81 NPC1 (0.41) S1PR1S1PR5S1PR3MEN1NPC1
SCHEMBL6000151 0.80 GCGR (0.41) S1PR1S1PR5S1PR3MEN1NPC1
SCHEMBL6000607 0.79 MEN1 (0.44) MEN1NPC1RAB9AKMT2APOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060122181-A1 Heteroaromatic pentacyclic compound and medicinal use thereof JAPAN TOBACCO INC. (JP) 2006-06-08 US claimed
EP-1553091-A1 HETEROAROMATIC PENTACYCLIC COMPOUND AND MEDICINAL USE THEREOF JAPAN TOBACCO INC. (JP) 2005-07-13 EP claimed
US-20060122181-A1 Heteroaromatic pentacyclic compound and medicinal use thereof JAPAN TOBACCO INC. (JP) 2006-06-08 US disclosed
EP-1553091-A1 HETEROAROMATIC PENTACYCLIC COMPOUND AND MEDICINAL USE THEREOF JAPAN TOBACCO INC. (JP) 2005-07-13 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060122181-A1 Heteroaromatic pentacyclic compound and medicinal use thereof PTPN11, PTPN1, PTPN3 S1PR1 740/4885S1PR4 1253/4885S1PR5 1297/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.